BioCentury
ARTICLE | Financial News

Sophiris planning NASDAQ follow-on

February 16, 2013 1:30 AM UTC

Sophiris Bio Inc. (TSX:SHS) plans to list on NASDAQ and raise up to $74.8 million in a follow-on underwritten by Citigroup; Leerink; Stifel; and Lazard. This half, Sophiris plans to start the first of...